Value £36

Trimtech Therapeutics

VC Funding

Seed

Healthcare & Biotech Published 23 June 2026

LinkedIn X Email

Summary

Trimtech Therapeutics has raised an additional £10.6m in seed funding, bringing the total for the round to £35.6m.

Summary of transaction details:

Value: £35.6m
Sector: Healthcare & Biotech
Advisor: Not disclosed
Key Entities: Trimtech Therapeutics, Johnson & Johnson Innovation – JJDC, BGF
Location: Not disclosed

Note: The funding will support Trimtech Therapeutics as it progresses its proprietary platforms and differentiated portfolio, aiming to transform the course of treatment for neurodegenerative and inflammatory diseases.

Lead Investor / Acquirer

Johnson

Lead Investor / Acquirer

Johnson Innovation – JJDC

Lead Investor / Acquirer

BGF

Advising Broker

Undisclosed Firm

Related Deals in Healthcare & Biotech

Seed prioritised

VC Funding

Ternary Therapeutics

£3,600,000

Mar 2026

VC Funding

Syndex Bio

£11,500,000

Feb 2026

VC Funding

Gener8

£2,000,000

Jul 2024

VC Funding

Apposite Healthcare Growth I

£100,000,000

Apr 2026

View Company Details

Financials, officers, full deal history

Original Source

View the original press release or news article describing this transaction in full.

Read Original Post

AI Insight Lenses

Pro

AI-generated analysis from four professional perspectives. Powered by PE Deals.

Free to all registered users.